Cell Genesys, Inc. (CEGE)

drummerboy1985 (< 20) Submitted: 2/20/08 12:52 PM : Start Price: $2.90 CEGE Score: -56.75

This stock is big because of a drug that has been shown to help prostate cancer patients to live longer. Everyone knows that it's a really big deal right now in this country. Below is what an analyst thinks about this stock. I'm calling higher.

"We continue to believe that Cell Genesys is undervalued and has not benefited from the continuous and striking positive clinical data flow to date," said Canaccord Adams analyst Joseph Pantginis, who reaffirmed a "Buy" rating with a $7.70 price target.

Report this Post Replies: 0 | Reply